Glenmark's post-marketing surveillance shows no safety...

New Delhi [India], September 15 (ANI): The Glenmark Pharmaceuticals' post-marketing surveillance (PMS) study has...

Glenmark Pharma reports revenue growth of 26% and PAT growth...

Mumbai (Maharashtra) [India], August 14 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited, a research-led global...

Fitch affirms Glenmark Pharmaceuticals at BB on IPO of API...

Singapore, August 10 (ANI): Fitch Ratings has affirmed Glenmark Pharmaceuticals Ltd's long-term issuer default...

Glenmark, Canada's SaNOtize to commercialise nasal spray for...

Mumbai (Maharashtra) [India], August 2 (ANI): Glenmark Pharmaceuticals and Canadian biotech firm SaNOtize Research...

Glenmark to conduct phase III trials of nasal spray it claims...

New Delhi [India], July 8 (ANI): Glenmark Pharmaceuticals will be conducting a Phase III trial on a nasal spray,...

Fitch affirms Glenmark Pharmaceuticals at BB with stable outlook

Singapore, July 6 (ANI): Fitch Ratings has affirmed Glenmark Pharmaceuticals Ltd's long-term issuer default rating...

Glenmark Pharmaceuticals receives ANDA tentative approval for...

Mumbai (Maharashtra) [India], June 25 (ANI/PRNewswire): Glenmark Pharmaceuticals Ltd (Glenmark) has received...

Glenmark Pharmaceuticals receives ANDA approval for...

Mumbai (Maharashtra) [India], June 23 (ANI/PRNewswire): Glenmark Pharmaceuticals Ltd (Glenmark) has received final...

Glenmark releases interim data from PMS Study on Favipiravir...

Mumbai (Maharashtra) [India], June 9 (ANI/PRNewswire): Glenmark Pharmaceuticals, a research-led, global integrated...

Glenmark Pharmaceuticals receives ANDA approval for...

Mumbai (Maharashtra) [India], June 4 (ANI/PRNewswire): Glenmark Pharmaceuticals Ltd (Glenmark) has received final...

Glenmark Pharmaceuticals launches Rufinamide Tablets USP, 200...

Mumbai (Maharashtra) [India], June 1 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited (Glenmark) has launched...

Glenmark's consolidated revenues grow 2.8% to Rs. 1,09,439 Mn...

Mumbai (Maharashtra) [India], May 31 (ANI/PRNewswire): EBITDA growth of 22.7 per cent to Rs 20,844 Mn with margins...